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What are the novel findings of this work? 
The rate of fetal anomalies missed at US and detected only at fetal MRI is lower than what was 
previously reported in the published literature. The large majority of anomalies detected exclusively 
on MRI involve mainly migration disorders and hemorrhage which can be difficult to detect on US 
and tend to have a later presentation during pregnancy 
 
What are the clinical implications of this work? 
This is the largest study exploring the role of fetal brain MRI in detecting associated anomalies not 
diagnosed on US in fetuses with mild and moderate VM. This study support the practice of MRI 
assessment in every fetus with a prenatal diagnosis of VM, although parents can be reassured of the 
low risk of associated anomalies, when VM is isolated. 
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ABSTRACT 
Objectives: To assess the role of fetal magnetic resonance imaging (MRI) in detecting associated 
anomalies in fetuses presenting with mild and moderate isolated ventriculomegaly (VM) 
undergoing multiplanar ultrasound (US) evaluation of fetal brain. 
Methods: Multicenter, retrospective, cohort study involving 15 referral fetal medicine centers in 
Italy, United Kingdom, and Spain. Inclusion criteria were fetuses affected by isolated VM on US, 
defined as VM with normal karyotype and no other additional central nervous system (CNS) and 
extra-CNS anomalies on US, undergoing detailed assessment of fetal brain via a multiplanar 
approach as suggested by ISUOG guidelines on fetal neurosonogram. The primary outcome of the 
study was to report the rate of additional CNS anomalies detected exclusively at prenatal MRI and 
missed at US, while the secondary aim was to estimate the incidence of additional anomalies 
detected exclusively after birth and missed at prenatal imaging (US and MRI). Sub-group analyses 
according to the gestational age at MRI (< vs ≥ 24 weeks of gestation), laterality of VM (unilateral 
vs bilateral), and severity of dilatation (mild vs moderate VM) were also performed. 
Results: Five-hundreds and fifty-six fetuses with a prenatal diagnosis of isolated fetal VM on US 
were included in the analysis. Additional structural anomalies were detected at prenatal MRI and 
missed at US in 5.4% (95% CI 3.8-7.6) of cases. When considering the type of anomalies, supra-
tentorial intra-cranial hemorrhage was detected on MRI in 26.7% of fetuses, while polymicrogyria 
and lissencephaly in 20.0% and 13.3% of cases, respectively. Hypoplasia of the corpus callosum 
was detected at MRI in 6.7% of cases, while dysgenesis in 3.3%. Fetuses with an associated 
anomaly detected only at MRI were more likely to have moderate compared to mild VM (60.0% vs 
17.7%, p<0.001), while there was no significant difference between the proportion of cases with 
bilateral VM between the two groups (p=0.2). The results of the logistic regression analysis showed 
that maternal body mass index (OR: 0.85, 95% CI 0.7-0.99, p= 0.030), the presence of moderate 
VM (OR: 5.8, 95% CI 2.6-13.4, p<0.001) and gestational age at MRI ≥24 weeks of gestation (OR: 
4.1, 95% CI 1.1-15.3, p= 0.038) were independently associated with the probability of detecting 
associated anomalies at MRI. Associated anomalies were detected exclusively at birth and missed at 
prenatal imaging in 3.8% of cases.  
Conclusions: The rate of associated fetal anomalies missed at US and detected only at fetal MRI in 
fetuses with isolated mild and moderate VM undergoing neurosonography is lower than that 
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previously reported. The large majority of these anomalies are difficult to detect on ultrasound.  The 
findings from this study support the practice of MRI assessment in every fetus with a prenatal 
diagnosis of VM, although parents can be reassured of the low risk of associated anomalies, when 
VM is isolated on US. 
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INTRODUCTION 
Ventriculomegaly (VM) is the most common brain anomaly diagnosed during fetal life and 
encompasses a large spectrum of conditions characterized by a dilatation of the lateral ventricles of 
the brain, typically defined as greater than 10 mm at the level of the atria.1-7 
VM is frequently classified according to the degree of ventricular dilatation as mild (10-12 mm), 
moderate (13-15 mm), or severe (>15 mm), with higher degrees of dilation being associated with an 
increased risk of neurodevelopmental delay.8 
The cause, severity and presence of associated anomalies are the major determinants in predicting 
the outcome of fetuses affected by VM. Thus, the main issue when approaching a fetus with VM is 
to rule out central nervous system (CNS) and extra-CNS anomalies.6 The International Society of 
Ultrasound in Obstetrics and Gynecology (ISUOG) recommends that every fetus presenting with 
isolated VM on ultrasound should undergo a thorough multiplanar examination through axial, 
coronal and sagittal views of the fetal brain, possibly performed with a high-resolution vaginal 
probe. Moreover, a detailed assessment of the entire fetal anatomy, including fetal 
echocardiography, should also be undertaken.9 
Ultrasound (US) is the primary imaging tool for the assessment of fetal brain, while fetal magnetic 
resonance imaging (MRI) has been shown to detected additional anomalies in 20% to 50% of 
cases.10-11 
In a recent systematic review, we found that in fetuses diagnosed with isolated VM, the rate of CNS 
anomalies detected exclusively on MRI was lower than that previously reported when a multiplanar 
assessment of the fetal brain is undertaken.9,12 However, the heterogeneity among the included 
studies make the results of this systematic review difficult to generalize.  
The primary aim of this study was to evaluate the role of fetal MRI in detecting associated 
anomalies in fetuses presenting with isolated mild and moderate VM undergoing multiplanar 
neurosonography and to ascertain whether the incidence of such anomalies is dependent upon the 
degree and laterality of ventricular dilatation and gestational age at MRI. The secondary aim was to 
estimate the incidence of additional anomalies detected exclusively after birth and missed at 
prenatal imaging (US and MRI). 
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METHODS 
Study design and participants  
This was a multicenter, retrospective, cohort study involving 15 referral centers in Italy, United 
Kingdom, and Spain. The study included pregnant women who had fetal brain MRI following the 
diagnosis of isolated VM performed by neurosonography from January 2010 to March 2019. Only 
cases with at post-natal imaging or post-mortem examination, in case of termination of pregnancy 
or fetal demise, were included. The clinical records were examined and data were collected in a 
dedicated merged database.  
 
Inclusion criteria 
• Fetuses affected by isolated mild (10-12 mm), moderate (13-15 mm) VM at US, defined as 
VM with no other additional CNS and extra-CNS on the scan 
• Detailed assessment of fetal brain via a multiplanar approach as suggested by 2007 ISUOG 
guidelines on fetal neurosonogram9 
• Detailed fetal assessment including echocardiography 
• Normal karyotype (including chromosomal microarray, when available) 
• Negative infection screening (including CMV and Toxoplasmosis) 
• Maternal Age > 18 years 
• Gestational age > 18 weeks 
Exclusion criteria 
• Fetuses affected by severe (> 15 mm) VM at US cases of severe VM  
• Cases affected by chromosomal anomalies 
• Cases affected by additional CNS and extra-CNS anomalies at the time of initial diagnosis 
• Cases affected by congenital infections 
• US protocol unclear or unavailable 
 
Outcomes 
The primary outcome of the study was to establish the rate of additional CNS anomalies detected 
exclusively on MRI and confirmed at birth in fetuses with a prenatal diagnosis of isolated VM 
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following dedicated neurosonography. The secondary aim was to estimate the incidence of 
additional anomalies detected exclusively after birth and missed at prenatal imaging (US and MRI). 
Sub-group analyses according to the gestational age at MRI (< vs ≥ 24 weeks of gestation), 
laterality of VM (unilateral vs bilateral VM), and the severity of dilatation (mild vs moderate VM) 
were also performed.  
 
For the purpose of the analysis, additional CNS anomalies were classified into: 
• Callosal anomalies, including complete and partial agenesis (ACC), hypoplasia (HCC) and 
dysgenesis of the corpus callosum 
• Septal anomalies, including all the anomalies characterized by a primary defect involving 
the septum pellucidum with a normally present corpus callosum 
• Posterior fossa anomalies, including all defects involving the cerebellar vermis and/or 
hemispheres 
• Intra-ventricular hemorrhage  
• Cortical anomalies, including all abnormalities associated with a primary defect in neuronal 
migration towards the cortical surface of the brain 
• Peri-ventricular heterotopia 
• Other white matter anomalies 
• Peri-ventricular cysts 
• Complex brain anomalies, including all defects characterized by the presence of multiple 
intra-cranial anomalies 
• Other cerebral anomalies 
 
We did not consider biometric variation in brain structures, such as mega cisterna magna, increased 
or reduced degree of ventricular dilatation or of cranial size, as associated anomalies.   
 
Statistical analysis 
We investigated the relationship between the presence of ventriculomegaly-associated structural 
anomalies, assessed through fetal MRI (primary outcome) and a number of maternal and fetal 
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characteristics, including mother's age and body mass index (BMI), ventriculomegaly severity and 
laterality, gestational age at US and MRI assessment. As a secondary outcome, we investigated the 
relationship between the same maternal/fetal parameters and a postnatal diagnosis of 
ventriculomegaly-associated anomalies in fetuses with isolated VM (following negative prenatal 
imaging). 
The potential association between all recorded maternal and fetal parameters and the two outcomes 
were first evaluated with standard univariate analyses (chi-squared test for categorical variables; 
Kruskal-Wallis test for continuous variables). For the secondary outcome, no multivariate analysis 
could be performed, because the number of newborns with a postnatal diagnosis of structural 
anomalies was limited to 11, and the likelihood of overfitting was too high.  
As regards the primary outcome, we investigated the potential independent predictors of a fetal 
MRI diagnosis of ventriculomegaly-associated anomalies with a twofold approach. First, we 
performed a random-effect logistic regression, with hospital region as the cluster unit. A stepwise 
forward process was used for model building, and the following criteria were adopted for covariates 
selection, which were limited to four in every step of the analysis to reduce the risk of overfitting: 
(1) p<0.05 at univariate analyses; (2) clinical significance; (3) the interval, expressed in weeks, 
between US and MRI examinations included a priori as a continuous variable. To avoid 
multicollinearity between the mean dilatation of cerebral ventricle (in mm) and the severity of 
ventriculomegaly (classified into "mild" and "moderate" according to the mm of dilatation), only 
the latter covariate was included in the model as a categorical variable. Standard post-estimation 
tests were used to check the validity of the final model, performing multicollinearity and influential 
observation analyses (using standardized residuals, change in Pearson and deviance chi-square).13-14 
Second, all analyses were repeated after multiple imputation with bootstrap option for missing 
values (m=5, mi Stata command),13-14 as 37% of the mother's BMI values were not reported. The 
results of the complete model were very similar to those of the random-effect logistic regression, 
and only the results of the model without missing imputation have been shown to avoid 
redundancy. Statistical significance was defined as a two-sided p-value<0.05 for all analyses,15 
which were carried out using Stata, version 13.1 (Stata Corp., College Station, Texas, USA, 2013). 
This study was reported following the STROBE guidelines.16 
 




Characteristics of the women 
Five-hundred and fifty-six fetuses with a prenatal diagnosis of isolated fetal VM were included in 
the analysis. The general characteristics of the study population are shown in Table 1. The mean 
maternal age was 32.0±5.9 years, while the mean BMI was 24.6±4.1. The mean gestational age at 
MRI was 26.7±4.4, with 30.9% of the scans performed before, while 69.1% performed at or after 
24 weeks of gestation. Of the included cases, 36.5% (95% CI 32.6-40.4; 203/556) were affected by 
bilateral, while 63.5% (95% CI 59.4-67.4; 353/556) by unilateral VM. Finally, VM was mild (10-12 
mm) in 80.0% (95% CI 76.5-83.2; 445/556) and moderate (13-15 mm) in 20.0% (95% CI 16.9-
23.5; 111/556) of the cases. 
Synthesis of the results 
Table 2 shows the results of the primary and secondary outcomes of study. Additional structural 
anomalies were detected exclusively by MRI in 5.4% (95% CI 3.8-7.6; 30/556) of cases. When 
considering the type of anomalies, supra-tentorial intra-cranial hemorrhage was detected 
exclusively at MRI in 26.7% (8/30) of cases, while polymicrogyria and lissencephaly in 20.0% 
(6/30) and 13.3% (4/30) of cases, respectively. HCC was detected only at MRI in 6.7% (2/30) of 
cases, while dysgenesis in 3.3% (1/30).  
The rate of associated anomaly detected exclusively at MRI was significantly higher in fetuses 
affected by moderate VM (60%), compared with fetuses affected by mild VM (17.7%)  ( p<0.001), 
while there was no significant difference between the proportion of cases with bilateral VM 
between the two groups (p=0.2). The majority (90.0%) of fetuses with associated anomalies had 
MRI performed at ≥24 weeks of gestation (Supplementary Table 1). 
 
The results of the logistic regression analysis showed that maternal BMI (OR: 0.85, 95% CI 0.7-
0.99, p= 0.030), the presence of moderate VM (OR: 5.8, 95% CI 2.6-13.4, p<0.001) and gestational 
age at MRI ≥24 weeks of gestation (OR: 4.1, 95% CI 1.1-15.3, p= 0.038) were independently 
associated with the probability of detecting associated anomalies at MRI (Table 3). 
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After birth, 3.8% (11/278) of cases with an isolated VM confirmed at prenatal MRI had associated 
anomalies detected exclusively at post-natal imaging (cranial ultrasound and/or post-natal MRI). 
Mean ventricular dilatation was significantly higher in fetuses with a post-natal diagnosis of 
associated anomalies compared to those who had isolated VM confirmed at post-natal imaging 
(13.0±1.5 vs 11.5±1.3, p= 0002). Furthermore, fetuses with a post-natal diagnosis of associated 
anomalies were more likely to be affected by bilateral 3 decimal points (81.8% vs 50.0%, p=0.04) 
and moderate (63.6% vs 18.7%, p<0.001) VM compared to those who were confirmed to be 
isolated after birth (Supplementary Table 2). 
 




Summary of the main findings 
The findings of this study show that in fetuses with prenatal diagnosis of isolated VM examined 
using multiplanar neurosonography, the rate of additional structural anomalies detected exclusively 
by fetal brain MRI was 5.4%. The most common type of anomalies included supra-tentorial intra-
cranial hemorrhage, and neuronal migration disorders. Factors independently associated with a 
higher incidence of additional findings detected exclusively at fetal MRI were gestational age at 
MRI ≥ 24 weeks, moderate ventricular dilatation and maternal BMI. Finally, the rate of associated 
anomalies detected exclusively after birth and missed at prenatal imaging was 3.8%. 
Strengths and limitations 
Large sample size, inclusion of cases examined using a multiplanar approach as proposed by 
ISUOG guidelines on fetal neurosonography and stratification of the analyses according to the 
degree and laterality of ventricular dilatation represent the main strengths of this study. The 
retrospective non-randomized design represents the main limitation of the study and led to 
challenges in obtaining all the details on the imaging for all the fetuses in the participating centers, 
with some incomplete follow‐up and some missing data, mostly related to the postnatal MRI or US 
and karyotyping. Furthermore, although 75.5% of fetuses underwent MRI two weeks or less after 
neurosonogram, 24.5% of fetuses underwent MRI after three to more than six weeks after US; 
therefore, it is likely that a prolonged interval between US and MRI may have somehow influenced 
our results. Finally, the present study included only cases having neurosonography performed in 
each participating center without exploring its feasibility according to different maternal and fetal 
characteristics.  
 
Implications for clinical practice and research 
Isolated VM represents a considerable diagnostic dilemma as it can be an apparently benign 
finding, but can also be associated with chromosomal abnormalities, congenital infections, cerebral 
vascular accidents or hemorrhage, and other fetal cerebral and extracerebral abnormalities.5-7 Even 
when isolated, VM has been reported to increase the risk of neurodevelopmental delay in childhood 
and adolescence. The prevalence of neurodevelopmental disorders in fetuses with both unilateral 
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and bilateral mild VM has been reported to be only slightly higher than that of the general 
population.17-19 Conversely, neurodevelopmental delay is higher in case of VM associated with 
additional CNS anomalies, and in case of severe ventricular dilatation.20-22 
 
The ISUOG guidelines on sonographic examination of the fetal CNS suggest that a multiplanar 
assessment of fetal head should be always performed when a suspicion of brain anomaly is raised at 
the basic US examination.9 Furthermore, in a recent consult series on mild VM, the Society for 
Maternal-Fetal Medicine (SMFM) has stated that MRI may be considered in cases of mild or 
moderate fetal VM, although it may be of less value if the women undergone detailed US 
assessment by an individual with specific experience and expertise in sonographic imaging of the 
fetal brain.8 
 
MRI is the imaging technique of choice in analyzing brain anomalies postnatally. Compared to US, 
MRI has a better regional resolution, thus being theoretically superior to US in detecting 
abnormalities of the cortical development. Based on these findings, the current practice today 
suggests a prenatal MRI examination in the late second, early third trimester of pregnancy, although 
there is no complete agreement among different authors regarding the need and time of MRI 
examination. However, the large majority of studies on MRI does not specify which type of 
ultrasound imaging protocol was adopted to assess fetal brain, and this is fundamental as most of 
CNS anomalies cannot be easily detected on the standard axial plane of fetal brain.12,23-29 
 
In 2017, a large prospective, multicenter study involving 16 centers across the United Kingdom (the 
MERIDIAN Study) was designed to evaluate the diagnostic and clinical role of fetal MRI in fetuses 
with a previous US with a suspicion or diagnosis of CNS anomaly.11 This study showed a much 
greater diagnostic accuracy of MRI compared to US (93% versus 68%), with additional findings 
detected exclusively on MRI in 49% of brain abnormalities and in up to 19.4% when focusing on 
the subgroup analysis of fetuses with mild and moderate VM.23 Of note, the rate of associated 
callosal anomalies detected exclusively on MRI was lower in our cohort compared to the 
MERIDIAN study (10% versus 55% of cases of failed commissuration).23  
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In the present study, the large majority of anomalies detected exclusively on prenatal MRI included 
neuronal migration (lissencephaly, heterotopia) or acquired anomalies (i.e. hemorrhage) which 
could be difficult to diagnose on ultrasound.30-34 In this scenario, fetal MRI should always be 
performed in order to rule out associated anomalies which can be potentially missed on ultrasound. 
Nevertheless, parents should be reassured regarding the low risk of such additional anomalies. 
 
In the present study, MRI performed at or after 24 weeks was an independent factor which was 
associated with the risk of additional anomalies detected exclusively at MRI. This finding might 
appear quite intuitive, as some abnormalities, such as malformations of cortical development, 
migration disorders and hemorrhage can become evident only later during pregnancy. Not 
surprisingly, the most frequent type of anomalies detected only at MRI in this study were 
hemorrhage and migration disorders, anomalies presenting mostly after the second trimester of 
pregnancy.35 However, some authors have suggested that early MRI (before 24 weeks of gestations) 
may be reliable and has similar accuracy as MRI performed later in gestation,11-12 with the 
advantage of an early diagnosis which can allow parents the option of earlier diagnosis, especially 
in countries where termination of pregnancy is not legal beyond the second trimester. 
 
Conclusions 
The rate of fetal anomalies missed at US and detected only at fetal MRI is lower than what was 
previously reported in the published literature when a multiplanar examination of fetal brain 
performed. The large majority of anomalies detected exclusively on MRI involve mainly migration 
disorders and hemorrhage which cannot be easily detected on ultrasound, thus highlight the need for 
an MRI examination  in fetuses with a prenatal diagnosis of VM undergoing neurosonography. 
Future research investigating prenatal diagnosis of isolated VM should aim at a multicenter 
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Table 1. Selected gestational and fetal characteristics in a sample of singleton pregnancies with a 
prenatal sonographic diagnosis of ventriculomegaly 
 




Mean maternal age in years (SD) 32.0 (5.9) 
  
Mean maternal BMI in kg/m2 (SD) 24.6 (4.1) 
  
Gestational age at prenatal MRI diagnosis of additional anomalies in weeks:  
  
- Mean gestational age at diagnosis (SD) 26.7 (4.4) 
- Diagnosis <24 weeks, % 30.9 
- Diagnosis ≥24 weeks, % 69.1 
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Interval between prenatal US and MRI examinations in weeks:  
  
- Mean interval (SD) 2.2 (2.5) 
- ≤2 weeks, % 75.5 
- 3-5 weeks, % 11.3 
- ≥6 weeks, % 13.2 
  
Characteristics of fetal ventriculomegaly: 
  
Bilateral ventriculomegaly, % 36.5 
  
Severity, %  
- Mild  80.0 
- Moderate 20.0 
  
Mean ventricular dilatation in mm (SD):  
- Overall 11.6 (1.3) 
- Mild ventriculomegaly 11.1 (0.7) 
- Moderate ventriculomegaly 13.8 (0.8) 
  
Mean dilatation of the controlateral ventricle in mm (SD)** 11.8 (1.4) 
  
SD: Standard deviation; US: ultrasound; MRI, magnetic resonance imaging 



















Fetuses with additional structural anomalies detected through prenatal MRI, % 5.4 
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Type of prenatal-diagnosed anomaly, % *  
- Hemorrhage 26.7 
- Polymicrogyria 20.0 
- Lissencephaly 13.3 
- Corpus Callosum hypoplasia 6.7 
- Periventricular heterotopia 6.7 
- Others 26.6 
  
Newborn with additional structural anomalies detected through postnatal MRI, % ** 3.8 
 
* N=30 fetuses with additional anomalies detected through prenatal MRI 
** Analyses restricted to 289 newborn (both the fetuses with a prenatal diagnosis of structural anomaly and the 
newborn without a postnatal MRI exam were excluded).
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Table 3. Logistic regression models evaluating the potential independent predictors of a prenatal MRI 
diagnosis of ventriculomegaly-associated anomalies 
 
Covariates Adjusted OR (95% CI) P value 
   
Model 1 *   
   
Maternal BMI, 1-unit increase 0.85 (0.74-0.99) 0.030 
   
Severity of ventriculomegaly, moderate vs mild 5.84 (2.55-13.4) <0.001 
   
Interval between US and MRI assessment, 1-week increase 1.00 (0.84-1.21) 0.919 
   
Gestational age at MRI diagnosis, ≥ versus < 24 weeks 4.07 (1.09-15.3) 0.038 
   
 
* Random-effect logistic regression with Hospital region as the cluster level. 
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